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  The density of intestinal endocrine cells, in Balb/c mice 
with  colon  26  (CT-26)  carcinoma  cells,  were  examined   
immunohistochemically  at  28  days  after  implantation. 
After CT-26 cell administration there was a significant de-
crease in most of the intestinal endocrine cells (p ＜ 0.01) 
compared with the control group. The significant quantitative 
changes in the intestinal endocrine cell density might contribute 
to the development of the gastrointestinal symptoms commonly 
encountered in cancer patients. 
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Introduction 
  There has been extensive research on gastrointestinal (GI) 
endocrine cells in mouse strains, including normal Balb/c 
mice [3,10-12]. Changes in GI endocrine cells with some 
diseases have been demonstrated [1,5,14,15]. Although almost 
50% of the most common  distressing symptoms reported 
in cancer patients are GI in nature [9], studies on  changes 
in the GI endocrine cells have been limited  to the region of 
endocrine carcinoid tissues or nonneoplastic mucosa 
around the carcinoids [15,18]. In addition, there is no ex-
perimental data on changes in the GI endocrine cell profile 
after subcutaneous administration of tumor cells with the 
exception of 3LL cells. After introducing 3LL cells, the   
intestinal endocrine cells, particularly those related to the 
intestinal motility, decreased markedly. [12] In addition, a 
marked decrease in chromogranin cells, a common marker 
for endocrine cells [2], was detected after administration of 
CT-26 cells [7]. However, there are no reports on changes 
of individual GI endocrine cells in the intestines of Balb/c 
mice after subcutaneous implantation of CT-26 cells.
  The aim of this study was to clarify the changes, in  individual 
endocrine cells, in the intestines  of Balb/c mice after the 
subcutaneous  implantation  of  CT-26  cells  by  specific       
immunohistochemistry using  antisera against serotonin, 
somatostatin, glucagons, gastrin, cholecystokinin (CCK)-8, 
and human pancreatic polypeptide (hPP).
Materials and Methods
Experimental Animals
  Twenty adult female Balb/c mice (6-weeks old, 21-26 g of 
body weight upon receipt) were purchased from the 
Charles River Laboratories (Japan) and used after allowing 
1 week for acclimatization. The animals were placed 5 per 
autoclaved filter-top cage (Nalgene, USA) in a temperature 
(20-25ºC) and humidity (50-55%) controlled room during 
the acclimatization period. The light:dark cycle was 12 h：12 
h and sterilized feed (Samyang, Korea) and autoclaved water 
were supplied ad libitum. The animals were divided into 
two groups containing 10 mice each: a CT-26 cell implanted 
group and a control sham group. The experimental protocols 
were carried out in accordance with internationally-accepted 
principles for laboratory animal use and care, as found in 
the Korea Food and Drug Administration guidelines.
Implantation of CT-26 tumor cells 
  The CT-26 cells were maintained as a subcutaneous tumor 
mass. The subcutaneous tumor mass was excised under 
sterile conditions and single cell suspensions were prepared 
using  collagenase type IV and Dnase I (Sigma- Aldrich, 
USA) in phosphate-buffered saline (PBS) followed by filtration 
of the resulting tumor cell suspension through a cell strainer 
(Costar, USA). After counting and adjusting the number of 
cells (1 × 10
5 cells/mouse), the viable CT-26 cells were im-
planted under the abdominal skin. PBS only was injected 10    Kwang-Ho Cho et al.
Table 1. Antisera used in this study
Antisera raised* Source Dilution
Serotonin
Somatostatin
Glucagon
Gastrin
CCK-8
†
hPP
‡
BioGenex, USA
BioGenex, USA
Dia Sorin,USA
BioGenex, USA
Dia Sorin, USA
DAKO, USA
1 : 100
1 : 100
1 : 2,000
1 : 20
1 : 500
1 : 600
*All antisera were raised in rabbits; 
†CCK-8: cholecystokinin-8, 
‡hPP: 
human pancreatic polypeptide.
Table 2. Regional distribution and density of the endocrine cells in the small intestine of Balb/c mice with and without implantation of
CT-26
           Antisera
Non-implanted sham CT-26 implanted group
Duodenum Jejunum Ileum Duodenum Jejunum Ileum
Serotonin
Somatostatin
hPP
†
Gastrin
CCK-8
‡
Glucagon
15.90 ± 4.70
ND
§
 0.70 ± 0.67
 1.20 ± 0.42
 1.20 ± 0.42
ND
6.30 ± 1.64
ND
ND
ND
ND
ND
3.10 ± 0.99
ND
ND
ND
ND
ND
 7.70 ± 2.06*
ND
ND
ND
1.10 ± 0.32
ND
2.20 ± 0.63*
ND
ND
ND
ND
ND
2.90 ± 0.74
ND
ND
ND
ND
ND
Remarks: Mean ± SD, Number of IR cells among 1,000 epithelial and intestinal acinar cells (1 field in each animal, total 10 fields); 
†hPP: human
pancreatic polypeptide. 
‡CCK-8: cholecystokinin-8; 
§ND, not detected; *p ＜ 0.01 compared with sham.
Table 3. Regional distribution and density of the endocrine cells in the large intestine of Balb/c mice with and without implantation of
CT-26
      Antisera
Non-implanted sham CT-26 implanted group
Cecum Colon Rectum Cecum Colon Rectum
Serotonin
Somatostatin
hPP
†
Gastrin
CCK-8
‡
Glucagon
5.80 ± 1.23
ND
§
ND
ND
ND
ND
12.00 ± 3.50
ND
ND
ND
ND
ND
7.50 ± 2.22
ND
ND
ND
ND
ND
1.70 ± 0.82*
ND
ND
ND
ND
ND
6.60 ± 2.46*
ND
ND
ND
ND
ND
3.00 ± 1.76*
ND
ND
ND
ND
ND
Remarks: Mean ± SD, Number of IR cells among 1,000 epithelial and intestinal acinar cells (1 field in each animal, total 10 fields); 
†hPP: human
pancreatic polypeptide. 
‡CCK-8: cholecystokinin-8; 
§ND, not detected; *p ＜ 0.01 compared with sham.
subcutaneously at the same site of the sham control group.
Sampling 
  Twenty-eight days after implantation (mean lengths of 
long axis of tumor cell masses in CT-26 cell implanted 
group were 1.35 ± 0.22 cm), the animals were fasted for ap-
proximately 24 h. After phlebotomy, samples from six re-
gions of the intestinal tract, the duodenum, jejunum, ileum, 
cecum, colon, and rectum were removed and fixed in 
Bouin's solution.
Histology 
  After paraffin embedding, 3-4 µm serial sections were 
prepared. Representative sections of each tissue were 
stained with hematoxylin and eosin for optical microscopy 
examination of the normal intestinal architecture.
Immunohistochemistry 
  Each representative section was deparaffinized, rehydrated 
and immunostained using the peroxidase anti-peroxidase 
(PAP) method [17]. The sections were incubated with nor-
mal goat serum for 1 hr at room temperature in a humidity 
chamber to block nonspecific reactions. After rinsing 3 
times in 0.01 M PBS, pH 7.4, the sections were incubated 
with the specific primary antisera listed in Table 1 for 18 h Decrease of intestinal endocrine cells after CT 26-implantation in Balb/c mice    11
Fig. 1. Serotonin-IR cells in the duodenum (A, D), jejunum (B, E), ileum (C, F), cecum (G, J), colon (H, K) and rectum (I, L) of the 
non-implanted sham group (A-C, G-I) and CT-26 implanted group (D-F, J-L). In the CT-26 implanted group, serotonin-IR cells were
markedly decreased in the intestinal regions except for the ileum. PAP methods. Scale bars = 80 µm.
at 4ºC in a humidity chamber. After rinsing in PBS, the sections 
were incubated in secondary antiserum (Sigma, USA) for 
1 hr at room temperature in a humidity chamber. The sections 
were then washed in PBS buffer and incubated with the 
PAP complex (Sigma, USA) for 1 hr at room temperature 
in a humidity chamber. The peroxidase reaction was carried 
out in a 3,3'-diaminobenzidine tetrahydrochloride (Sigma, 
USA) solution containing 0.01% H2O2 in 0.05 M Tris-HCl 
buffer (pH 7.6). After immunostaining, the sections were 
lightly counterstained with Mayer’s hematoxylin and the 12    Kwang-Ho Cho et al.
Fig. 2. HPP- (A) and gastrin- (B) IR cells in the duodenum of the
non-implanted sham group. These cells were not detected in the 
CT-26 implanted group. PAP methods. Scale bars = 80 µm.
immunoreactive (IR) cells were observed by optical micro-
scopy.
  The specificity of each immunohistochemical reaction 
was determined using the method recommended by 
Sternberger [17], which included the replacement of specific 
antiserum by the same antiserum that had been preincubated 
with its corresponding antigen.
Frequency
  IR cells showing immunoreactivity against each antiserum 
were counted in the restricted view fields on a computer 
monitor using an automated image analysis process (Soft 
Image System, Germany) that was coupled to an optical 
microscope; at least 1,000 epithelial and intestinal acinar 
cells per slide were evaluated. In each animal, the density 
of the IR cells was calculated as the mean ± SD of 10 fields 
per each intestinal region.
Statistical analysis
  The Mann-Whitney U-Wilcoxon Rank Sum W test was 
used to examine the significance of the data with SPSS for 
Windows (Release 6.1.3; SPSS, USA), and the significant 
values are represented by an asterisk (p ＜ 0.01).
Results
  In this study, four types of IR endocrine cells were detected 
in the intestines of Balb/c mice; against serotonin, gastrin, 
hPP, and CCK-8. Serotonin- and CCK-8-IR cells were 
identified in the CT-26 implanted- and sham groups, while 
the hPP- and gastrin-IR cells were observed only in the 
sham group. On the other hand, the somatostatin- and gluca-
gon-IR cells were not detected in any of the intestinal samples 
evaluated in this study. According to the location in the    
 intestine, different regional distributions and densities of 
these IR cells were observed, as shown in Tables 2 and 3. 
Most of the IR cells in the epithelial regions were generally 
spherical or spindle-shaped, while round cells were occa-
sionally found in the regions of intestinal glands. 
  Serotonin-IR cells were observed in the entire intestines 
of the sham and CT-26 implanted groups. The serotonin-IR 
cells were dispersed throughout the intestinal mucosa, 
mainly among the surface epithelium and intestinal glands 
in both the sham and implanted groups (Fig. 1). They 
showed the highest density in the duodenum in both 
groups. The number of serotonin-IR cells in the entire in-
testines of the CT-26 implanted group was significantly (p 
＜ 0.01) lower than in the sham group except for the ileum, 
where there was similar cell numbers (Tables 2 and 3). 
Approximately 51.6, 65.1, 6.5, 70.7, 45.0, and 60.0% of 
the serotonin-IR cells in the duodenum, jejunum, ileum, 
cecum, colon, and rectum of the CT-26 implanted group 
compared with the sham, respectively.  No somatostatin-IR 
cells in the intestines of the CT-26 implanted or sham group 
were observed (Tables 2 and 3).  No glucagon-IR cells 
were detected in the intestines of the CT-26 implanted and 
non-implanted groups (Tables 2 and 3). A few hPP-IR cells 
were found in the intestinal glands   of the duodenum of the 
sham (Fig. 2A), but no cells were observed in the CT-26 
implanted group (Tables 2 and 3).  A few gastrin-IR cells 
were detected in the intestinal glands of the duodenum of 
the sham group (Fig. 2B) but no gastrin-IR cells were observed 
in the CT-26 implanted group (Tables 2 and 3).  CCK-8-IR 
cells were restricted to the duodenum of both groups, and 
they were dispersed over the surface epithelium or the  
intestinal glands of the intestinal mucosa regardless of im-
plantation of CT-26 cells (Figs. 3A-C). The number of 
CCK-8-IR cells in the duodenum of the CT-26 implanted 
group was similar to the sham group (about 8.3% was de-
creased) (Tables 2 and 3).
Discussion
  CT-26 cells are rectal carcinoma cells that are established 
by administrating N-methylmorpholine N-oxide to Balb/c 
mice. These cells are transplantable to Balb/c mice and are 
widely used tumor cells for studies of antitumor agents [4]. 
CT-26 cell implantation resulted in a significant decrease 
of the number of IR cells (p ＜ 0.01) in the intestinal tract. 
The most significant changes were noted in the cecum and 
the greatest changes were detected with serotonin-IR cells. 
These changes might be responsible for inducing some of 
the GI abnormalities observed in cancer patients [9]. The 
changes observed were similar to those previously detected 
after implantation of 3LL cells [12].
  Serotonin inhibits the secretion of gastric acids, and induces 
smooth muscle contractions in the GI tract [6]. The marked 
decrease in the number of serotonin-IR cells, in the CT-26 
bearing mice, might be responsible for some of the GI 
problems in cancer patients, particularly those related to 
gastric motility and gastric acid secretion. The decrease in 
the number of gastrin-IR cells detected in this study may 
cause digestive problems, particularly with regard to gastric Decrease of intestinal endocrine cells after CT 26-implantation in Balb/c mice    13
Fig. 3. CCK-8-IR cells of the duodenum of the non-implanted sham group (A, B) and CT-26 implanted group (C). No meaningful 
changes of CCK-8-IR cells were detected after implantation of CT-26 in the present study. PAP methods. Scale bars = 80 µm.
acid secretion since gastrin secreted by the intestinal G 
cells promotes gastric acid secretion [16].  CCK secretion 
by intestinal I cells stimulates pancreatic enzyme secretion 
[16]. However, there was no change in the number of CCK- 8-IR 
cells observed in this study. Although the precise function 
of PP is unknown, it is generally accepted that their action 
is related to exocrine pancreatic functions [11]. Therefore, 
the absence of these IR cells, detected in this study, may 
cause abnormalities in exocrine pancreatic digestive 
functions.
  Somatostatin inhibits the secretion of other neuroendocrine 
hormones [8]. It is well known that somatostatin-IR cells 
have the widest distribution throughout the GI tract, except 
for the large intestine, among all vertebrate species examined 
using serotonin-IR cells [11]. However, somatostatin-IR 
cells were not detected in this study; this finding may be a 
strain-specific characteristic of Balb/c mice [10].
  In conclusion, endocrine cells are the anatomical units   
responsible for the production of GI hormones. Any 
change in the density of these cells may result in the alteration 
of the production of important GI hormones.  The results of 
this study showed that the implantation of a tumor cell 
mass (CT-26) induced severe quantitative changes in the 
intestinal endocrine cell density. This alteration of endo-
crine cell density might contribute to the development of 
gastrointestinal symptoms such as anorexia and indiges-
tion, which are frequently encountered in cancer patients.
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